Sinovac Biotech科兴生物
Explore the data
Revenue
Source: Nasdaqwww.nasdaq.com/market-activity/stocks/sva/financials
Source: Nasdaqwww.nasdaq.com/market-activity/stocks/sva/financials
Employees
Source: Sinovac 2019 annual reportsec.report/Document/0001564590-20-020204/sva-20f_20191231.htm
Source: Sinovac 2019 annual reportsec.report/Document/0001564590-20-020204/sva-20f_20191231.htm
Valuation
Source: Yahoo Financefinance.yahoo.com/quote/SVA/key-statisticsNotes: Valuation is reported as market capitalization. It was last updated on September 13, 2022 13:48:12.
Source: Yahoo Financefinance.yahoo.com/quote/SVA/key-statisticsNotes: Valuation is reported as market capitalization. It was last updated on September 13, 2022 13:48:12.
Overview
Source: Sinovac Websitewww.sinovac.com/Source: Reuterswww.reuters.com/article/health-coronavirus-sinovac/piecemeal-data-releases-threaten-to-undermine-sinovacs-covid-19-vaccine-idUSL4N2J80L1Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: FTwww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
Source: Sinovac Websitewww.sinovac.com/Source: Reuterswww.reuters.com/article/health-coronavirus-sinovac/piecemeal-data-releases-threaten-to-undermine-sinovacs-covid-19-vaccine-idUSL4N2J80L1Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: FTwww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
Sinovac Biotech Ltd. is a biopharmaceutical company best known globally for its COVID-19 vaccine CoronoVac, which was the No. 1 most-used in the world as of September 2021.
CoronaVac has made up a significant proportion of the 2 billion doses administered in China and 693 million sent abroad, along with peer company Sinopharm’s shot.
Aside from its COVID-19 vaccine, Sinovac focuses on drug research, development, manufacturing, and commercialization. Based in Beijing, it also produces vaccines for hepatitis A and B, influenza, H5N1, H1N1, mumps, and canine rabies.
Fast facts
- Full ENGLISH Name
- Sinovac Biotech Ltd.
- Full Chinese Name
- 科兴控股生物技术有限公司
- WEBSITE
- http://www.sinovacbio.com
- TICKER SYMBOL
- NYSE: SVA
- Year founded
Source: Sinovac Websitewww.sinovac.com/
- 1999
- COMPANY TYPE
- Publicly Traded
Ownership
| English Name | Chinese Name | Percent Ownership | Ultimate Beneficiary | Share Class |
|---|---|---|---|---|
Prime Success, L.P.
| 8.25% | |||
|
Vivo Capital
| 8.25% | |||
|
CDH Utopia Limited
| 8.39% | |||
|
1Globe Capital LLC
| 4.69% | |||
|
SAIF Partners IV
| 15.07% |
Subsidiaries
| English Name | Chinese Name | Percent Held |
|---|
Leadership
| English Name | Chinese Name | Title |
|---|
Latest News
-
- headline
- date
- source
- tags
DUE DILIGENCE
We’re still working on the data for this profile. Add it to your Watchlist to get all the latest updates.